RE:RE:RE:RE:RE:RE:RE:Given what we now know… After all of these years, for the company to achieve BTD would certainly be a remarkable accomplishment and a significant financial advantage. That being said, it is also helpful if not comforting to me to recognize that Accelerated Approval designation is not dependent upon whether a drug is given BTD status. From what I understand, AA can be granted before/during/after BTD. Of course, AA allows the company to immediately market its drug which, in turn, creates revenues and value....with a corresponding vault in equity.
I love BTD....I'm keeping my eyes on AA.